Inovio developing a swine flu vaccine

Inovio is developing a swine flu vaccine. Here's the headline: "Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to Evaluate Candidate DNA Vaccines Against “Swine” Influenza A (H1N1)"

Inovio has established a new collaboration with the National Microbiology Laboratory of the Public Health Agency of Canada and the University of Pennsylvania to further evaluate Inovio DNA vaccine candidates against swine influenza A (H1N1) virus. Dr. J. Joseph Kim (no, that's not me), Inovio’s CEO, stated, “The current swine flu outbreak highlights the fact that the world cannot rely solely on the “catch-up” strategy of influenza vaccine design. We need vaccines that provide at least some broad protective capability against evolving seasonal influenza strains and those with pandemic potential. We have already achieved significant validating data in large animal models regarding the ability of Inovio’s consensus vaccines to protect against unmatched strains of different influenza sub-types and look forward to the data resulting from this collaboration of vaccine experts.”